Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Medicine
|
June 1, 2017
Identification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and database
Pei-Chien Tsai, Ta-Wei Liu, Yi-Shan Tsai, et al.
World Journal of Gastroenterology
|
March 17, 2025
Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes
Ming-Ying Lu, Yu-Ju Wei, Chih-Wen Wang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
April 9, 2017
Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohort
Ta-Wei Liu, Pei-Chien Tsai, Ching-I Huang, et al.
American Journal of Cancer Research
|
February 13, 2023
Decision tree algorithm predicts hepatocellular carcinoma among chronic hepatitis C patients following viral eradication
Ming-Ying Lu, Ta-Wei Liu, Po-Cheng Liang, et al.
Journal of Gastroenterology and Hepatology
|
April 5, 2020
Serial serologic changes of hepatitis D virus in chronic hepatitis B patients receiving nucleos(t)ides analogues therapy
Tyng-Yuan Jang, Yu-Ju Wei, Cheng-Ting Hsu, et al.
World Journal of Gastroenterology
|
February 7, 2022
Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication
Ming-Ying Lu, Ming-Lun Yeh, Ching-I Huang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
October 28, 2020
Role of hepatitis D virus in persistent alanine aminotransferase abnormality among chronic hepatitis B patients treated with nucleotide/nucleoside analogues
Tyng-Yuan Jang, Yu-Ju Wei, Ming-Lun Yeh, et al.
World Journal of Gastroenterology
|
February 3, 2022
Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison
Chun-Ting Chen, Ming-Ying Lu, Meng-Hsuan Hsieh, et al.
Scientific Reports
|
April 15, 2021
Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues
Tyng-Yuan Jang, Yu-Ju Wei, Ta-Wei Liu, et al.
American Journal of Cancer Research
|
January 11, 2023
Artificial intelligence based on serum biomarkers predicts the efficacy of lenvatinib for unresectable hepatocellular carcinoma
Po-Yao Hsu, Po-Cheng Liang, Wen-Tsan Chang, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Medicine
|
June 1, 2017
Identification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and database
Pei-Chien Tsai, Ta-Wei Liu, Yi-Shan Tsai, et al.
World Journal of Gastroenterology
|
March 17, 2025
Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes
Ming-Ying Lu, Yu-Ju Wei, Chih-Wen Wang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
April 9, 2017
Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohort
Ta-Wei Liu, Pei-Chien Tsai, Ching-I Huang, et al.
American Journal of Cancer Research
|
February 13, 2023
Decision tree algorithm predicts hepatocellular carcinoma among chronic hepatitis C patients following viral eradication
Ming-Ying Lu, Ta-Wei Liu, Po-Cheng Liang, et al.
Journal of Gastroenterology and Hepatology
|
April 5, 2020
Serial serologic changes of hepatitis D virus in chronic hepatitis B patients receiving nucleos(t)ides analogues therapy
Tyng-Yuan Jang, Yu-Ju Wei, Cheng-Ting Hsu, et al.
World Journal of Gastroenterology
|
February 7, 2022
Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication
Ming-Ying Lu, Ming-Lun Yeh, Ching-I Huang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
October 28, 2020
Role of hepatitis D virus in persistent alanine aminotransferase abnormality among chronic hepatitis B patients treated with nucleotide/nucleoside analogues
Tyng-Yuan Jang, Yu-Ju Wei, Ming-Lun Yeh, et al.
World Journal of Gastroenterology
|
February 3, 2022
Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison
Chun-Ting Chen, Ming-Ying Lu, Meng-Hsuan Hsieh, et al.
Scientific Reports
|
April 15, 2021
Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues
Tyng-Yuan Jang, Yu-Ju Wei, Ta-Wei Liu, et al.
American Journal of Cancer Research
|
January 11, 2023
Artificial intelligence based on serum biomarkers predicts the efficacy of lenvatinib for unresectable hepatocellular carcinoma
Po-Yao Hsu, Po-Cheng Liang, Wen-Tsan Chang, et al.
Page
of 5